The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Newly Unified Unilever Sets Out Growth Ambitions

Thu, 04th Feb 2021 08:21

(Alliance News) - Consumer products giant Unilever said Thursday it delivered a strong set of annual results under the most difficult of circumstances brought about by the coronavirus pandemic, while also setting out a plan for growth.

Unilever shares were down 3.9% at 4,168.00 pence early Thursday.

For 2020, Unilever posted revenue of EUR50.72 billion, down 2.4% from USD51.98 billion in 2019, just missing forecasts of EUR50.81 billion.

Underlying operating profit was EUR9.34 billion in 2020, down from EUR9.94 billion in 2019. The Anglo-Dutch company posted underlying sales growth of 1.9%.

Unilever declared a quarterly dividend of EUR0.4268, which it noted was up 4%. This is about 37.7 pence.

Looking ahead, Unilever said it would aim for underlying sales growth ahead of its markets, delivering growth in the range of 3% to 5%, as well as profit growth ahead of sales growth.

CEO Alan Jope said: "We progressed our strategic agenda, building on our existing sustainability commitments with ambitious new targets and actions, most recently with our plans to help build a more equitable and inclusive society. We completed the unification of our legal structure under a single parent company and we continue to work on separating out the tea business as we evolve our portfolio.

"Today we are setting out our plans to drive long-term growth through the strategic choices we are making and outlining our multi-year financial framework. While volatility and unpredictability will continue throughout 2021, we begin the year in good shape and are confident in our ability to adapt to a rapidly changing environment."

Other elements of Unilever's plan is to develop its product portfolio into "high growth spaces". It also will push harder to grow in the US, India and China, from which 35% of it turnover already comes.

Unilever said it make restructuring investment of EUR1 billion in each of 2021 and 2022, with this reducing thereafter. It is aiming for EUR2 billion per annum of savings from its established 'Fuel for Growth' effort.

It is targeting return on invested capital in the mid-to-high teens and a ratio of net debt to underlying earnings before interest, tax, depreciation and amortisation of about 2 times.

Back in November, Unilever completed the unification of its group legal structure into a single parent company headquartered in the UK but still listed in Amsterdam, New York and London.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.4% at 6,530.66

----------

Hang Seng: down 0.7% at 29,101.74

Nikkei 225: closed down 1.1% at 28,341.95

DJIA: closed up 36.12 points, or 0.1%, at 30,723.60

S&P 500: closed up 3.86 points, or 0.1%, at 3,830.17

----------

GBP: down at USD1.3598 (USD1.3651)

EUR: down at USD1.2003 (USD1.2022)

Gold: down at USD1,825.03 per ounce (USD1,835.90)

Oil (Brent): up at USD58.94 a barrel (USD58.64)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's Key Economic Events still to come

0930 GMT UK CIPS-Markit construction purchasing managers' index

1100 GMT Ireland industrial production and turnover

1200 GMT UK Bank of England interest rate decision

1200 GMT UK BoE quarterly monetary policy report

1300 GMT UK BoE Governor Andrew Bailey press conference

1100 CET EU retail sales

0730 EST US challenger job-cut report

0830 EST US preliminary productivity and costs

0830 EST US initial jobless claims

1030 EST US EIA weekly natural gas storage report

----------

Former European Central Bank chief Mario Draghi urged Italy's splintered parties Wednesday to get behind him as he tries to form a new government and lift his country out of the devastation of the coronavirus pandemic. After receiving a mandate from President Sergio Mattarella to open talks on a national unity government, Draghi stressed the urgency of resolving the political chaos at such a "difficult moment". There has been no fully functioning government in Rome for weeks, as Giuseppe Conte's ruling coalition slowly collapsed in a row over the handling of Covid-19 and the resulting deep recession.

----------

BROKER RATING CHANGES

----------

DEUTSCHE BANK CUTS GLAXOSMITHKLINE TO 'SELL' (HOLD) - PRICE TARGET 1150 (1400) PENCE

----------

ODDO BHF RAISES RELX TO 'OUTPERFORM' (NEUTRAL)

----------

JEFFERIES RAISES PRUDENTIAL TO 'BUY' (HOLD) - PRICE TARGET 1450 (1455) PENCE

----------

GOLDMAN SACHS RAISES ASOS PRICE TARGET TO 6,500 (5,800) PENCE - 'BUY'

----------

COMPANIES - FTSE 100

----------

Shell swung to an annual loss in a year when the Covid-19 pandemic hit energy consumption. Brent oil was quoted at USD58.90 a barrel Thursday morning, up from USD58.64 at the London equities close Wednesday. The North Sea benchmark was trading around USD68 a barrel at the start of 2020, but collapsed to a low of USD15.97 in April due to the global economic impact of the virus and a Russia-Saudi Arabia output war later resolved. For 2020, Shell swung to a loss attributable to shareholders of USD21.68 billion from a profit of USD15.84 billion in 2019. Adjusted earnings were USD4.84 billion, down 71% from USD16.46 billion - missing consensus forecasts for USD5.05 billion. For the fourth quarter alone, Shell swung to a loss attributable to shareholders of USD4.01 billion from a USD965 million profit in 2019. Free cash flow for 2020 was USD17.63 billion, down 12% from USD20.1 billion in 2019. Net debt increased by USD1.9 billion to USD75.4 billion in the fourth quarter, hurt by lower free cash flow, including a small working capital outflow. Shell slashed its fourth quarter payout 65% to USD0.1665 from USD0.4700. Its annual dividend was down 65% to USD0.6530. Shell expects its first quarter 2021 dividend to be USD0.1735. Looking ahead to the first quarter, Shell said production was expected in a range between 900,000 to 950,000 barrels of oil per day. "2020 was an extraordinary year. We have taken tough but decisive actions and demonstrated highly resilient operational delivery while caring for our people, customers and communities. We are coming out of 2020 with a stronger balance sheet, ready to accelerate our strategy and make the future of energy. We are committed to our progressive dividend policy and expect to grow our US dollar dividend per share by around 4% as of the first quarter 2021," said Chief Executive Officer Ben van Beurden.

----------

COMPANIES - GLOBAL

----------

SoftBank Group said its performance improved in the first nine months of its current financial year. The Tokyo-based company which owns stakes in many technology, energy, and financial companies said revenue for the nine months to the end of 2020 rose by 5.2% when compared to the prior year to JPY3.807 trillion. Pretax profit, meanwhile, increased by 2.3% to JPY746.20 billion. Operating income was 5.8% higher than a year earlier, at JPY841.58 billion. Net income rose by 3.5% to JPY485.50 billion.

----------

Basel, Switzerland-based pharmaceutical group Roche Holdings reported a stronger performance for 2020, with profit rising despite a drop in sales. For the year, Roche posted net income of CHF15.07 billion, around USD20.07 billion, which reflects a 7% rise from CHF14.11 billion the year before, due to a drop in goodwill write-offs. Diluted earnings per share however was down 5% year-on-year at CHF19.16 from CHF20.16. Group sales however, declined by 5% to CHF58.32 billion from CHF61.47 billion in 2019, which Roche attributed to the continued appreciation of the Swiss franc against most currencies. At constant exchange rates however, sales rose by 1%.

----------

Thursday's Shareholder Meetings

Compass Group PLC - AGM

DCC PLC - GM re replacement of CREST system

Hostelworld Group PLC - GM re changes to borrowing limit

Microsaic Systems PLC - GM re share placing

Octopus Renewables Infrastructure Trust PLC - GM re investment policy changes

Sage Group PLC - AGM

Stock Spirits Group PLC - AGM

Ten Lifestyle Group PLC - AGM

Yew Grove REIT PLC - EGM re migration from CREST

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.